Medical cannabis sales in Connecticut in April decreased for the first time since adult-use sales commenced in the state, according to state data outlined by CT Insider. Medical cannabis sales in April totaled $11.4 million, down from $12.6 million in March, but were still higher than adult-use sales in April, which reached $10.2 million.
Adult-use cannabis sales in Connecticut commenced in January and totaled $5.1 million, while medical cannabis sales reached just over $8 million. In February, adult-use sales were just over $7 million, while medical cannabis sales totaled $11.4 million. In March, adult-use sales climbed to about $9.6 million, with medical sales totaling about $12.6 million.
The price of medical cannabis since the launch of adult-use sales has remained stable, with an average product price of $35.68 in January, $36.11 in February, $37.06 in March, and $36.51 in April, according to state data. Adult-use prices have declined since the $44.61 average seen during the January market launch. In February, the average price was $41.82; $40.69 in March; and $39.58 in April.
Despite the strong medical cannabis sales, patient counts are on the decline in the state. In January, there were 48,896 registered medical cannabis patients, compared to 46,048 in April.
Ganjapreneur: Offering daily insights since 2014, the leading digital business journal for cannabis industry professionals. Subscribe to the newsletter to join our community of over 40,000 ganjapreneurs.
